Glaukos Corp (GKOS)
144.00
+3.17
(+2.25%)
USD |
NYSE |
Nov 22, 16:00
144.11
+0.11
(+0.08%)
After-Hours: 20:00
Glaukos Cash from Investing (Quarterly): 30.56M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 30.56M |
| June 30, 2024 | 34.86M |
| March 31, 2024 | -29.38M |
| December 31, 2023 | -12.92M |
| September 30, 2023 | 14.90M |
| June 30, 2023 | 25.95M |
| March 31, 2023 | -13.83M |
| December 31, 2022 | 16.66M |
| September 30, 2022 | 24.39M |
| June 30, 2022 | 9.63M |
| March 31, 2022 | -5.897M |
| December 31, 2021 | -8.872M |
| September 30, 2021 | -26.06M |
| June 30, 2021 | -2.034M |
| March 31, 2021 | -21.26M |
| December 31, 2020 | -3.459M |
| September 30, 2020 | -181.56M |
| June 30, 2020 | -20.67M |
| March 31, 2020 | 0.628M |
| December 31, 2019 | 49.81M |
| September 30, 2019 | -4.074M |
| June 30, 2019 | -0.599M |
| Date | Value |
|---|---|
| March 31, 2019 | -1.713M |
| December 31, 2018 | -17.75M |
| September 30, 2018 | -5.932M |
| June 30, 2018 | 2.538M |
| March 31, 2018 | -5.254M |
| December 31, 2017 | -7.69M |
| September 30, 2017 | -1.443M |
| June 30, 2017 | -1.155M |
| March 31, 2017 | -2.102M |
| December 31, 2016 | -2.858M |
| September 30, 2016 | -10.17M |
| June 30, 2016 | -4.603M |
| March 31, 2016 | -8.487M |
| December 31, 2015 | -70.13M |
| September 30, 2015 | -0.183M |
| June 30, 2015 | -15.10M |
| March 31, 2015 | -0.215M |
| December 31, 2014 | -0.291M |
| September 30, 2014 | -0.268M |
| June 30, 2014 | -0.12M |
| March 31, 2014 | -0.189M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-181.56M
Minimum
Sep 2020
49.81M
Maximum
Dec 2019
-5.928M
Average
-2.746M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Baxter International Inc | -164.00M |
| Masimo Corp | -13.50M |
| Teleflex Inc | -21.23M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.586M |
| Cash from Financing (Quarterly) | 9.668M |
| Free Cash Flow | -81.27M |
| Free Cash Flow Per Share (Quarterly) | -0.2005 |
| Free Cash Flow to Equity (Quarterly) | -11.10M |
| Free Cash Flow to Firm (Quarterly) | -11.04M |
| Free Cash Flow Yield | -1.11% |